ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

223
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
09 Dec 2018 22:56

Takeda and Shire Shareholders Unanimously Agree to $64b Deal

Our take… Reiterating our positive view, we think the deal could help Takeda on several fronts, including: Sizeable footprint in the strategically...

05 Dec 2018 23:59

Takeda/Shire VI: Now For The Real Fun

At today's AGM, Takeda Pharmaceutical (4502 JP) shareholders approved the agenda items required to approve and complete the Scheme with Shire PLC...

Logo
1.8k Views
Share
28 Nov 2018 16:59

Takeda/Shire V: Tradition vs the Next Generation, Former Chairman Doesn't Support But...

Early this morning, the Nikkei carried an article (English version) saying that former Takeda Pharmaceutical (4502 JP) CEO and Chairman Kunio...

Logo
760 Views
Share
25 Nov 2018 06:35

Last Week in Event SPACE: Alpine/Alps, Renault, Takeda, Trade Me, Holcim, Toshiba, GMO

Last Week in Event SPACE ... In the sordid and ongoing war for the hearts and minds of investors in Alpine Electronics (6816 JP), ISS says take...

Logo
822 Views
Share
22 Nov 2018 07:00

2Q Earnings Is the Time for Full-Year Guidance Revisions. See Who Changed Their Numbers the Most....

At the beginning of the fiscal year, Japanese companies issue full-year guidance. Most of them will then revise those number when they announce 2Q...

Logo
476 Views
Share
x